Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Fixes Retail...

NPPA Fixes Retail Prices of 62 Formulations, Details

Written By : Susmita Roy |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-09-14T18:00:11+05:30  |  Updated On 14 Sept 2024 6:00 PM IST
NPPA Fixes Retail Prices of 62 Formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of India, has fixed retail prices for 62 formulations under the Drugs (Prices Control) Order, 2013.

The list of formulations includes Ibuprofen and Paracetamol Suspension, manufactured and marketed by Innova Captab/ Dr. Reddy’s Laboratories, Telmisartan, Amlodipine and Hydrochlorothiazide tablets, manufactured and marketed by Akums Drugs and Pharmaceuticals/Sun Pharmaceutical Industries, Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets manufactured and marketed by Akums Drugs & Pharmaceutical and others.

This comes after exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), has fixed, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit, and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Ibuprofen & Paracetamol Suspension

Each 5ml contains: Ibuprofen IP 100 mg, Paracetamol IP 162.5mg

1 ml

M/s Innova Captab Ltd/ M/s Dr. Reddy’s Laboratories Ltd

0.50

2

Telmisartan, Amlodipine & Hydrochlorothiazide tablets

Each film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besilate IP eq to Amlodipine 5mg,

Hydrochlorothiazide IP 12.5mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd/ M/s Sun Pharmaceutical Industries Ltd

10.23

3

Telmisartan, Cilnidipine & Chlorthalidone tablets

Each film coated tablet contains:

Telmisartan IP 40mg, Cilnidipine IP 10mg, Chlorthalidone IP 12.5mg

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd.

14.73

4

Telmisartan, Chlorthalidone & Amlodipine tablets

Each film coated tablet contains:

Telmisartan IP 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to

Amlodipine 5mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Eris Lifesciences Limited

10.65

5

Telmisartan, Cilnidipine & Chlorthalidone Tablets

Each film coated bilayered tablet contains: Telmisartan IP 40mg,

Cilnidipine IP 10mg, Chlorthalidone IP 12.5 mg

1 Tablet

M/s Windlas Biotech Ltd. / M/s Emcure Pharmaceuticals Limited

14.85

6

Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets

Each film coated bilayered tablet contains:

Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to

Amlodipine 5mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited

13.20

7

Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets

Each film coated bilayered tablet contains:

Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to

Amlodipine 5mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Akumentis Healthcare Ltd.

13.20

8

Metoprolol Succinate (ER), Cilnidipine & Telmisartan tablets

Each film coated bilayer tablet contains:

Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited

9.82

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

(As Extended release from),

Cilnidipine IP 10mg, Telmisartan IP 40mg

9

Metoprolol Succinate (ER), Cilnidipine & Telmisartan Tablets

Each film coated bilayer tablet contains:

Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (As Extended release from), Cilnidipine IP 10mg,

Telmisartan IP 40mg

1 Tablet

M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited

12.50

10

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg

1 Tablet

M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.

11.21

11

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg

1 Tablet

M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.

9.65

12

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited

9.65

13

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg

1 Tablet

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited

11.21

14

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals

Ltd.

9.65

15

Bisoprolol Fumarate and Telmisartan Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 5 mg,

Telmisartan IP 40 mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals

Ltd.

11.21

16

Levofloxacin Infusion IP

Each 100ml Contains: Levofloxacin Hemihydrate IP eq to Levofloxacin 500mg, Sodium

Chloride IP 900 mg

1 ml

M/s Pure and Cure Healthcare Pvt Ltd/ M/s Dr Reddy’s Laboratories Ltd

1.51

17

Moxifloxacin Eye drops IP

Composition:

Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v

1 ml

M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt.

Ltd.

27.00

18

Moxifloxacin & Ketorolac Tromethamine Eye drops IP

Composition:

Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP 0.4% w/v Benzalkoniumchloride Solution 0.01%v/v (as

preservative)

1 ml

M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.

25.32

19

Moxifloxacin & Dexamethasone Eye drops

Composition:

Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v, Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate

0.1%w/v

1 ml

M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.

25.04

20

Ofloxacin & Dexamethasone Sodium Phosphate Ophthalmic Solution

Composition: Ofloxacin IP 0.3% w/v, Dexamethasone Sodium Phosphate IP eq. to

Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride Solution IP 0.02%w/v (as

preservative)

1 ml

M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.

5.24

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

21

Chloramphenicol & Dexamethasone Sodium Phosphate Eye/Ear drops

Composition: Chloramphenicol IP 1%w/v, Dexamethasone Sodium Phosphate IP 0.1%w/v, Phenyl Mercuric Nitrate Ip 0.002%w/v

(as preservative)

1 ml

M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.

5.88

22

Tobramycin & Dexamethasone Ophthalmic Solution

Composition:

Tobramycin Sulfate USP eq to Tobramycin 0.3%w/v, Dexamethasone Sodium Phosphate IP eq to Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride

Solution IP 0.02%v/v (as preservative)

1 ml

M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.

5.78

23

Aceclofenac, Paracetamol & Serratiopeptidase Tablets

Each film coated tablet contains:

Aceclofenac IP 100mg, Paracetamol IP 325mg, Serratiopeptidase IP 15mg (As enteric coated tablet eq. to enzyme

activity 30000 units)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd.

9.74

24

Mefenamic Acid and Paracetamol Tablets

Each uncoated tablet contains:

Mefenamic Acid IP 250mg Paracetamol IP 325mg

1 Tablet

M/s Blue Cross Laboratories Pvt. Ltd.

3.82

25

Paracetamol and Mefenamic Acid

suspension

Each 5ml contains: Mefenamic Acid 100mg, Paracetamol IP

250mg

1 ml

M/s Windlas Biotech Limited / M/s Biological E.

Limited

0.90

26

Diclofenac Sodium Injection IP

Each ml contains:

Diclofenac Sodium IP 75mg

1 ml

M/s Fast Pharma Pvt. Ltd. / M/s Cadila

Pharmaceuticals Ltd.

28.70

27

Lactulose Enema 20% w/v

Each ml contains:

Lactulose Concentrate USP eq. to Lactulose 200mg, Benzyl Alcohol

IP 3mg

1 ml

M/s Merril Pharma Private Ltd. / M/s Alkem Laboratories Ltd.

1.19

28

Cefadroxil and Clavulanic Acid dispersible Tablets

Each uncoated dispersible tablet contains:

Cefadroxil Monohydrate IP eq. to Cefadroxil 250mg,

Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5mg

1 Tablet

M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited

9.30

29

Cefadroxil and Clavulanic Acid Tablets

Each film coated tablet contains:

Cefadroxil Monohydrate IP eq. to Cefadroxil 500mg

Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg

1 Tablet

M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited

17.61

30

Ferrous Ascorbate and Folic Acid Suspension IP

Each 5ml contains: Ferrous Ascorbate IP eq. to Elemental Iron 30mg

Folic Acid IP 550mcg

1 ml

M/s Tirupati Medicare Ltd.

/ M/s Intas Pharmaceuticals Ltd.

0.95

31

Combi pack of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP

Each Strip contains:

  1. Clarithromycin Tablets IP 2 Tablets

Each film coated tablet contains: Clarithromycin IP 500mg

  1. Esomeprazole Tablets IP 2 Tablets

Each Enteric coated tablet contains:

Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg

  1. Amoxicillin Tablets USP 2

Tablets

Combi kit pack

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Limited

166.74

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Each Film coated tablet contains:

Amoxycillin Trihydrate IP eq. to Amoxycillin 750mg

32

Etoricoxib and Paracetamol Tablets

Each Film Coated tablet contains:

Etoricoxib IP 60 mg (As Micronized), Paracetamol IP 325 mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Pharmed Limited

9.15

33

Etoricoxib and Paracetamol Tablets

Each film coated Tablet contains:

Etoricoxib IP 60mg (As micronized)

Paracetamol IP 325mg

1 Tablet

M/s Synokem Lifesciences Pvt. Ltd. / M/s Cipla Ltd.

9.15

34

Levosalbutamol & Ipratropium Bromide respirator solution

Each 2.5 ml contains: Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to

Ipratropium (Anhydrous) 500 mcg

1 ml

M/s Axa Parenterals Limited / M/s Workcell Solutions Private Limited

5.75

35

Povidone Iodine Gargle

Composition:

Povidone-Iodine IP 2% w/v (Available Iodine 0.2% w/v) Ethanol 95% IP eq. to Absolute Alcohol 8.38% v/v

1 ml

M/s Pontika Aerotech Limited / M/s Abbott Healthcare Pvt. Ltd.

1.96

36

Omeprazole & Domperidone Capsules IP

Each hard gelatin capsule contains:

Omeprazole IP 20mg (as Enteric coated),

Domperidone IP 10mg (As Instant release)

1 Capsule

M/s Hetero Healthcare Ltd.

6.28

37

Tolperisone Hydrochloride and Paracetamol Tablets

Each film coated tablet contains:

Tolperisone Hydrochloride IP 150mg,

Paracetamol IP 325mg

1 Tablet

M/s Pure and cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.

13.95

38

Escitalopram Tablets

Each film coated tablet contains:

Escitalopram Oxalate IP eq. to Escitalopram 15mg

1 Tablet

M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.

13.00

39

Escitalopram Oxalate + Clonazepam Tablets

Each film coated tablet contains:

Escitalopram Oxalate IP eq. to Escitalopram 5mg, Clonazepam IP 0.25mg

1 Tablet

M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.

7.74

40

Escitalopram Oxalate + Clonazepam Tablets

Each film coated tablet contains:

Escitalopram Oxalate IP eq. to Escitalopram 20mg, Clonazepam IP 0.5mg

1 Tablet

M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.

19.67

41

Atorvastatin and Aspirin Capsules

Each hard gelatin capsule contains:

Atorvastatin Calcium IP eq. to Atorvastatin 10mg,

Aspirin IP 150mg (As two enteric coated tablet USP 75mg)

1 Capsule

M/s Unison Pharmaceuticals Pvt. Ltd.

2.54

42

Riboflavin, Folic Acid Niacinamide & Lactic Acid Bacillus Tablets

Each uncoated tablet contains:

Riboflavin IP 10mg, Folic Acid IP 1.5mg, Niacinamide IP 100mg,

Lactic Acid Bacillus 60Million

Spores

1 Tablet

M/s Prosperity Drugs Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.

4.11

43

Empagliflozin and Metformin Hydrochloride

Tablets

Each film coated tablet contains: Empagliflozin 5mg,

Metformin Hydrochloride IP

1 Tablet

M/s Mankind Pharma Limited

15.84

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

500mg

44

Empagliflozin and Metformin Hydrochloride Tablets

Each film coated tablet contains: Empagliflozin 12.5 mg,

Metformin Hydrochloride IP 1000mg

1 Tablet

M/s Mankind Pharma Limited

19.01

45

Empagliflozin and Metformin Hydrochloride Tablets

Each film coated tablet contains: Empagliflozin 12.5 mg,

Metformin Hydrochloride IP 500mg

1 Tablet

M/s Mankind Pharma Limited

18.10

46

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets

Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg,

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

15.32

47

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets

Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg,

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP

500mg (as Sustained Release Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited

14.00

48

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets

Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg,

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited

15.32

49

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets

Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg,

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500mg (as Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited

14.00

50

Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets

Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate

Monohydrate IP eq. to Sitagliptin 100mg,

Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release

Form)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited

15.32

51

Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited

11.60

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

50mg,

Metformin Hydrochloride IP 1000mg,

Glimepiride IP 1 mg

52

Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg,

Metformin Hydrochloride IP 1000mg,

Glimepiride IP 2 mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited

11.60

53

Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets

Each film coated bilayer Tablet contains:

Linagliptin 5mg,

Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP

1000mg (as sustained release form)

1 Tablet

M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.

20.33

54

Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets

Each film coated bilayer Tablet contains:

Linagliptin 5mg,

Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 500mg (as sustained release form)

1 Tablet

M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.

18.92

55

Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Vildagliptin IP 100mg (as sustained release), Metformin Hydrochloride IP

1000mg (as sustained release)

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd.

11.70

56

Empagliflozin + Metformin Hydrochloride Tablets

Each film coated tablet contains: Empagliflozin 5mg

Metformin Hydrochloride IP

850mg

1 Tablet

M/s Mankind Pharma Limited

11.51

57

Empagliflozin+ Metformin Hydrochloride Tablets

Each film coated tablet contains: Empagliflozin 5mg

Metformin Hydrochloride IP 1000mg

1 Tablet

M/s Mankind Pharma Limited

11.38

58

Empagliflozin+ Metformin Hydrochloride Tablets

Each film coated tablet contains: Empagliflozin 12.5mg

Metformin Hydrochloride IP 850mg

1 Tablet

M/s Mankind Pharma Limited

17.24

59

Calcium carbonate + Magnesium Hydroxide + Zinc Sulphate + Vitamin D3 tablets

Each film coated tablet contains:

Magnesium Hydroxide IP eq. to Elemental Magnesium 50mg, Vitamin D3 IP 1000IU,

Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 10mg,

Calcium Carbonate IP eq. to Elemental Calcium 500mg

1 Tablet

M/s Unison Pharmaceuticals Pvt. Ltd.

10.00

60

Dapagliflozin + Metoprolol tablets

Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg,

Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg

(as Sustained release)

1 Tablet

M/s ERIS Lifesciences Limited

16.77

S. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (in

Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

61

Montelukast + Bilastine tablets

Each film coated tablet contains:

Montelukast Sodium IP Eq. to Montelukast 10mg,

Bilastine IP 40mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Sun Pharma Laboratories Limited

28.76

62

Montelukast + Bilastine tablets

Each film coated tablet contains:

Montelukast Sodium IP Eq. to Montelukast 10mg,

Bilastine IP 40mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Sun Pharmaceutical Industries Limited

28.76

The notification further added:

(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

To view the official notice, click the link below:

/servlet/RDESController?command=rdm.ServletFileDisplay&app=rdes&partner=medical&type=20&sessionId=RDWEBFFSBVPEFZBWJCNG77SJ5MSKQC1HV1SAT&uid=
nppapriceretail priceprice fixationakums drugs & pharmaSun Pharmaceutical Industries
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

    Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

    U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or...

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Aspirin in Primary Prevention: Prudent Guideline-Based Approach

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium Sulfide in Seborrheic Dermatitis Management

    Environmental Impact on Seborrheic Dermatitis, Tinea versicolor and Dandruff: The Role of Selenium...

    View All

    Journal Club Today

    Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD

    Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD

    View All

    Health News Today

    Health Bulletin 20/June/2025

    Health Bulletin 20/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok